| Identification | Back Directory | [Name]
(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol | [CAS]
163706-58-9 | [Synonyms]
Cangrelor inter
Cangrelor Intermediate
Cangrelor Intermediates
Cangrelor Metabolite (Cangrelor Impurity 3)
N6-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)adenosine
N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]adenosine
Adenosine, N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]- (9CI)
(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)
((3aR,4R,6R,6aR)-6-(6-amino-2-((3,3,3-trifluoropropyl)thio)-9H- purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol
(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol Cangrelor Intermediate
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2- ((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol N6-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)adenosine | [EINECS(EC#)]
812-944-8 | [Molecular Formula]
C16H22F3N5O4S2 | [MDL Number]
MFCD15832982 | [MOL File]
163706-58-9.mol | [Molecular Weight]
469.5 |
| Chemical Properties | Back Directory | [Melting point ]
179-181°C | [Boiling point ]
747.5±70.0 °C(Predicted) | [density ]
1.70±0.1 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Sealed in dry,2-8°C | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
13.08±0.70(Predicted) | [color ]
White to Light Yellow |
| Hazard Information | Back Directory | [Uses]
N-?[2-?(Methylthio)?ethyl]?-?2-?[(3,?3,?3-?trifluoropropyl)?thio]?-adenosine is used for developing platelet P2T receptor antagonists, which have potential applications for antithrombotic therapy. |
|
|